

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.00419418 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.00419418 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.00419418 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.00419418 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.00419418 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.00419418 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.68027398 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.41458718 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 5.38570185 |
| 10 | regulation of interferon-alpha production (GO:0032647) | 5.11336339 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.05948246 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 5.05816337 |
| 13 | detection of other organism (GO:0098543) | 5.01715725 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.81472861 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80151379 |
| 16 | detection of bacterium (GO:0016045) | 4.78477281 |
| 17 | response to peptidoglycan (GO:0032494) | 4.76085623 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75380749 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.52730278 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.52730278 |
| 21 | respiratory burst (GO:0045730) | 4.52227133 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.29171375 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.29083436 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 4.24112160 |
| 25 | type I interferon signaling pathway (GO:0060337) | 4.21186608 |
| 26 | cellular response to type I interferon (GO:0071357) | 4.21186608 |
| 27 | response to type I interferon (GO:0034340) | 4.17368245 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.16830952 |
| 29 | response to host immune response (GO:0052572) | 4.16830952 |
| 30 | granulocyte activation (GO:0036230) | 4.12719573 |
| 31 | neutrophil activation (GO:0042119) | 4.12032585 |
| 32 | positive regulation of interferon-beta production (GO:0032728) | 4.11510443 |
| 33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.07737484 |
| 34 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.98673923 |
| 35 | cellular response to exogenous dsRNA (GO:0071360) | 3.97836156 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.93030474 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.89606848 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.88345858 |
| 39 | cellular response to zinc ion (GO:0071294) | 3.87578666 |
| 40 | detection of biotic stimulus (GO:0009595) | 3.82927411 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 3.82556523 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.76698485 |
| 43 | response to host (GO:0075136) | 3.76698485 |
| 44 | response to host defenses (GO:0052200) | 3.76698485 |
| 45 | microglial cell activation (GO:0001774) | 3.74202577 |
| 46 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.74090257 |
| 47 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.73541059 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.72233697 |
| 49 | B cell mediated immunity (GO:0019724) | 3.70974615 |
| 50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.69555326 |
| 51 | positive regulation of mast cell degranulation (GO:0043306) | 3.67816016 |
| 52 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.67816016 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.62943614 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 3.62126628 |
| 55 | T cell migration (GO:0072678) | 3.60659472 |
| 56 | cellular extravasation (GO:0045123) | 3.60616415 |
| 57 | response to muramyl dipeptide (GO:0032495) | 3.60430169 |
| 58 | defense response to protozoan (GO:0042832) | 3.60036442 |
| 59 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.59492428 |
| 60 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.58122313 |
| 61 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.55473936 |
| 62 | positive regulation of B cell differentiation (GO:0045579) | 3.52725460 |
| 63 | regulation of B cell differentiation (GO:0045577) | 3.51714675 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.49042460 |
| 65 | natural killer cell mediated immunity (GO:0002228) | 3.47675238 |
| 66 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.47675238 |
| 67 | macrophage activation (GO:0042116) | 3.40603599 |
| 68 | leukocyte mediated cytotoxicity (GO:0001909) | 3.38901591 |
| 69 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34606031 |
| 70 | myeloid dendritic cell differentiation (GO:0043011) | 3.34167259 |
| 71 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.33924299 |
| 72 | neutrophil mediated immunity (GO:0002446) | 3.33783466 |
| 73 | response to interleukin-15 (GO:0070672) | 3.30541900 |
| 74 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.30078171 |
| 75 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.30034970 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 3.28749442 |
| 77 | cellular response to interferon-beta (GO:0035458) | 3.28412541 |
| 78 | regulation of mast cell activation (GO:0033003) | 3.28324271 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 3.28090683 |
| 80 | leukocyte aggregation (GO:0070486) | 3.26413519 |
| 81 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.25167189 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 3.25026168 |
| 83 | regulation of tolerance induction (GO:0002643) | 3.24434774 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23502198 |
| 85 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22862830 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22816821 |
| 87 | T-helper 1 type immune response (GO:0042088) | 3.22048684 |
| 88 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.18692315 |
| 89 | response to interferon-alpha (GO:0035455) | 3.17396432 |
| 90 | response to protozoan (GO:0001562) | 3.14554677 |
| 91 | positive regulation of interleukin-12 production (GO:0032735) | 3.14161845 |
| 92 | positive thymic T cell selection (GO:0045059) | 3.13446294 |
| 93 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.12110359 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10966662 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 3.10351659 |
| 96 | regulation of interferon-beta production (GO:0032648) | 3.09282036 |
| 97 | negative thymic T cell selection (GO:0045060) | 3.07100138 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05038366 |
| 99 | myeloid leukocyte activation (GO:0002274) | 3.03570577 |
| 100 | negative regulation of interleukin-12 production (GO:0032695) | 3.01657262 |
| 101 | leukocyte degranulation (GO:0043299) | 3.01347549 |
| 102 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.01267429 |
| 103 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.00938026 |
| 104 | I-kappaB phosphorylation (GO:0007252) | 3.00052318 |
| 105 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.99773564 |
| 106 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99760432 |
| 107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99324125 |
| 108 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.99050889 |
| 109 | cellular response to interleukin-15 (GO:0071350) | 2.98709759 |
| 110 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98646192 |
| 111 | negative T cell selection (GO:0043383) | 2.96745558 |
| 112 | negative regulation of viral genome replication (GO:0045071) | 2.96215406 |
| 113 | negative regulation of cell killing (GO:0031342) | 2.96190915 |
| 114 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96190915 |
| 115 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96145726 |
| 116 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96012932 |
| 117 | myeloid leukocyte mediated immunity (GO:0002444) | 2.95194528 |
| 118 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95162149 |
| 119 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.94503437 |
| 120 | pinocytosis (GO:0006907) | 2.94362142 |
| 121 | negative regulation of innate immune response (GO:0045824) | 2.92751231 |
| 122 | response to interferon-beta (GO:0035456) | 2.91565098 |
| 123 | lymphocyte chemotaxis (GO:0048247) | 2.91446269 |
| 124 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.91403292 |
| 125 | positive regulation of type 2 immune response (GO:0002830) | 2.90750967 |
| 126 | regulation of leukocyte degranulation (GO:0043300) | 2.89300834 |
| 127 | positive regulation of leukocyte degranulation (GO:0043302) | 2.88245631 |
| 128 | germinal center formation (GO:0002467) | 2.88144906 |
| 129 | regulation of interleukin-12 production (GO:0032655) | 2.86963425 |
| 130 | lymphocyte mediated immunity (GO:0002449) | 2.85744244 |
| 131 | regulation of mononuclear cell migration (GO:0071675) | 2.85054522 |
| 132 | NIK/NF-kappaB signaling (GO:0038061) | 2.83863264 |
| 133 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83518780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.19125610 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.82175161 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.58110564 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.57780089 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.51211913 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.00027170 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.88613424 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.83575705 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.52332976 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50132023 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.29264538 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.16396801 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02174663 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.97532231 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.62750635 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62003716 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.61765431 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.59277102 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.39923184 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38492219 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36045651 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.35806101 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09886003 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07864059 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04721126 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.02745791 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.01630466 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92568759 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91076015 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90850660 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89236604 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85215321 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82592467 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79558561 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.78872003 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.78489767 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.77860002 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.76945799 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73231622 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69987174 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67403103 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65597170 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60294188 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58601316 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57507072 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49297368 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47624901 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47552046 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45162274 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45027687 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42847582 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40112966 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39787088 |
| 54 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38359692 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35320466 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33289022 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32796452 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29713031 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27125736 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24769962 |
| 61 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.24625582 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23650599 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21173862 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19862756 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19455309 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16190112 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14902734 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14557641 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.13846461 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12292531 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12137507 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11382261 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10289060 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09604304 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09134836 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09098213 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07549773 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07034127 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05322832 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05297886 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02337744 |
| 82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96255340 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95908367 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94975762 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94282369 |
| 86 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87893325 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87761496 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87191117 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85699171 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84859063 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82906083 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80767126 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80108940 |
| 94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80055452 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79966605 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75375671 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.71121949 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.70374790 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69747710 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69288499 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68191022 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.68007721 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67013669 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.65282244 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.64806354 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64343012 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64279278 |
| 108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.64031241 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.62530545 |
| 110 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.61900688 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.61834964 |
| 112 | P300_27268052_Chip-Seq_Bcells_Human | 0.61754814 |
| 113 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.60097345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.14927918 |
| 2 | MP0003436_decreased_susceptibility_to | 3.58329390 |
| 3 | MP0003303_peritoneal_inflammation | 3.56475669 |
| 4 | MP0001790_abnormal_immune_system | 3.49470813 |
| 5 | MP0005387_immune_system_phenotype | 3.49470813 |
| 6 | MP0009785_altered_susceptibility_to | 3.37114548 |
| 7 | MP0000685_abnormal_immune_system | 3.23379330 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.19069021 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.13194415 |
| 10 | MP0002419_abnormal_innate_immunity | 3.11538320 |
| 11 | MP0001800_abnormal_humoral_immune | 3.09831892 |
| 12 | MP0005025_abnormal_response_to | 2.99620431 |
| 13 | MP0006082_CNS_inflammation | 2.98929638 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.91246137 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.81975339 |
| 16 | MP0005671_abnormal_response_to | 2.81719448 |
| 17 | MP0004510_myositis | 2.68398460 |
| 18 | MP0002723_abnormal_immune_serum | 2.67627558 |
| 19 | MP0003724_increased_susceptibility_to | 2.47944556 |
| 20 | MP0001819_abnormal_immune_cell | 2.47133826 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.44850176 |
| 22 | MP0009278_abnormal_bone_marrow | 2.22079999 |
| 23 | MP0001853_heart_inflammation | 2.06602850 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.05606948 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.03169223 |
| 26 | MP0002405_respiratory_system_inflammati | 2.02465532 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.92123234 |
| 28 | MP0000716_abnormal_immune_system | 1.91339918 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.89277021 |
| 30 | MP0002398_abnormal_bone_marrow | 1.87834499 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.78156184 |
| 32 | MP0009840_abnormal_foam_cell | 1.76147570 |
| 33 | MP0004947_skin_inflammation | 1.70162624 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.69436492 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.68283317 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.64505052 |
| 37 | MP0002132_abnormal_respiratory_system | 1.62811957 |
| 38 | MP0008469_abnormal_protein_level | 1.62448442 |
| 39 | MP0005451_abnormal_body_composition | 1.62077489 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.61655595 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.61655595 |
| 42 | MP0005310_abnormal_salivary_gland | 1.60316250 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.59828791 |
| 44 | MP0003075_altered_response_to | 1.58044721 |
| 45 | MP0002429_abnormal_blood_cell | 1.53917923 |
| 46 | MP0003448_altered_tumor_morphology | 1.53134866 |
| 47 | MP0009764_decreased_sensitivity_to | 1.52828465 |
| 48 | MP0002006_tumorigenesis | 1.52041389 |
| 49 | MP0000343_altered_response_to | 1.49679196 |
| 50 | MP0002722_abnormal_immune_system | 1.47054498 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.42171289 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.37239930 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.34876923 |
| 54 | MP0000604_amyloidosis | 1.22031855 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.21411275 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.21074833 |
| 57 | MP0010307_abnormal_tumor_latency | 1.15529603 |
| 58 | MP0000858_altered_metastatic_potential | 1.15135415 |
| 59 | MP0001873_stomach_inflammation | 1.10307452 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.09955937 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.09734058 |
| 62 | MP0004381_abnormal_hair_follicle | 1.05922721 |
| 63 | MP0003690_abnormal_glial_cell | 1.05626463 |
| 64 | MP0005166_decreased_susceptibility_to | 1.05539922 |
| 65 | MP0002933_joint_inflammation | 1.04847618 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.03904418 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.03546300 |
| 68 | MP0008004_abnormal_stomach_pH | 1.01504899 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.00088566 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.95446310 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 0.95437935 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 0.93647881 |
| 73 | MP0003828_pulmonary_edema | 0.91335104 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.89052557 |
| 75 | MP0005164_abnormal_response_to | 0.87915901 |
| 76 | MP0001851_eye_inflammation | 0.87637994 |
| 77 | MP0005390_skeleton_phenotype | 0.86900149 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.84581276 |
| 79 | MP0009763_increased_sensitivity_to | 0.84328756 |
| 80 | MP0003045_fibrosis | 0.82831343 |
| 81 | MP0000703_abnormal_thymus_morphology | 0.81315785 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.80045769 |
| 83 | MP0008057_abnormal_DNA_replication | 0.76744626 |
| 84 | MP0000371_diluted_coat_color | 0.75116121 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.74854614 |
| 86 | MP0000490_abnormal_crypts_of | 0.74046305 |
| 87 | MP0000249_abnormal_blood_vessel | 0.72393432 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.71625253 |
| 89 | MP0003866_abnormal_defecation | 0.71177141 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 0.69522932 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.67241886 |
| 92 | MP0008874_decreased_physiological_sensi | 0.64785770 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.64508373 |
| 94 | MP0003091_abnormal_cell_migration | 0.63995665 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.63792507 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.62893089 |
| 97 | MP0004883_abnormal_blood_vessel | 0.62016531 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.59033840 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.57680327 |
| 100 | MP0000920_abnormal_myelination | 0.57108242 |
| 101 | MP0001663_abnormal_digestive_system | 0.55595626 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55014548 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.52053195 |
| 104 | MP0003795_abnormal_bone_structure | 0.51416826 |
| 105 | MP0000767_abnormal_smooth_muscle | 0.50839445 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.49854000 |
| 107 | MP0000609_abnormal_liver_physiology | 0.49306826 |
| 108 | MP0005023_abnormal_wound_healing | 0.48346934 |
| 109 | MP0003329_amyloid_beta_deposits | 0.47849565 |
| 110 | MP0002009_preneoplasia | 0.47566138 |
| 111 | MP0001958_emphysema | 0.45367745 |
| 112 | MP0008260_abnormal_autophagy | 0.44209238 |
| 113 | MP0008873_increased_physiological_sensi | 0.43156299 |
| 114 | MP0009115_abnormal_fat_cell | 0.42854791 |
| 115 | MP0002928_abnormal_bile_duct | 0.42311518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.21761478 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.74862948 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.16941691 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.18832452 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.63322604 |
| 6 | Recurrent skin infections (HP:0001581) | 4.47670581 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.40290533 |
| 8 | Recurrent viral infections (HP:0004429) | 4.34278398 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.30809122 |
| 10 | Colitis (HP:0002583) | 4.29408251 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.28494858 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 4.09195692 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.01022911 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.99353623 |
| 15 | Myositis (HP:0100614) | 3.96397247 |
| 16 | Obstructive lung disease (HP:0006536) | 3.79624971 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.79624971 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.77699925 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.75882522 |
| 20 | Cellulitis (HP:0100658) | 3.74994760 |
| 21 | Chronic otitis media (HP:0000389) | 3.74035957 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.71880981 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.66085519 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.66085519 |
| 25 | Inflammation of the large intestine (HP:0002037) | 3.63108487 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.56650594 |
| 27 | Pustule (HP:0200039) | 3.56520206 |
| 28 | Gingivitis (HP:0000230) | 3.55094995 |
| 29 | Meningitis (HP:0001287) | 3.50030833 |
| 30 | Vasculitis (HP:0002633) | 3.47784548 |
| 31 | Gastrointestinal inflammation (HP:0004386) | 3.45789385 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.44334285 |
| 33 | Orchitis (HP:0100796) | 3.39862890 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.30417097 |
| 35 | Increased IgM level (HP:0003496) | 3.23694403 |
| 36 | Dysostosis multiplex (HP:0000943) | 3.23030049 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 3.20117762 |
| 38 | Glomerulonephritis (HP:0000099) | 3.18485350 |
| 39 | T lymphocytopenia (HP:0005403) | 3.12196431 |
| 40 | Periodontitis (HP:0000704) | 3.11448238 |
| 41 | Optic neuritis (HP:0100653) | 3.05517502 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 3.05517502 |
| 43 | Prolonged bleeding time (HP:0003010) | 3.04497103 |
| 44 | Spontaneous hematomas (HP:0007420) | 3.03450426 |
| 45 | Abnormality of T cell number (HP:0011839) | 3.00609180 |
| 46 | Hematochezia (HP:0002573) | 2.98680104 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.95957440 |
| 48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.95957440 |
| 49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.95957440 |
| 50 | Amyloidosis (HP:0011034) | 2.94530754 |
| 51 | Recurrent lower respiratory tract infections (HP:0002783) | 2.92713292 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.90051092 |
| 53 | Episodic fever (HP:0001954) | 2.80105358 |
| 54 | Recurrent pneumonia (HP:0006532) | 2.78730097 |
| 55 | Osteomyelitis (HP:0002754) | 2.78483946 |
| 56 | Stomatitis (HP:0010280) | 2.76337413 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73609221 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.73609221 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.70323860 |
| 60 | Basal ganglia calcification (HP:0002135) | 2.65372524 |
| 61 | Recurrent bronchitis (HP:0002837) | 2.64790612 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.62220726 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.62132200 |
| 64 | Urticaria (HP:0001025) | 2.61892292 |
| 65 | Hypochromic anemia (HP:0001931) | 2.60594131 |
| 66 | IgM deficiency (HP:0002850) | 2.59701560 |
| 67 | Pulmonary embolism (HP:0002204) | 2.59037773 |
| 68 | Anorexia (HP:0002039) | 2.58367139 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57744699 |
| 70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57744699 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57744699 |
| 72 | Myocardial infarction (HP:0001658) | 2.56394148 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.56045121 |
| 74 | Nasal polyposis (HP:0100582) | 2.56028740 |
| 75 | Disinhibition (HP:0000734) | 2.47219238 |
| 76 | Abnormality of the nasal mucosa (HP:0000433) | 2.46154786 |
| 77 | Loss of speech (HP:0002371) | 2.45432064 |
| 78 | Peritonitis (HP:0002586) | 2.41629284 |
| 79 | Gangrene (HP:0100758) | 2.38679534 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38623914 |
| 81 | Granulocytopenia (HP:0001913) | 2.38278739 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.38022659 |
| 83 | Encephalitis (HP:0002383) | 2.37404764 |
| 84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.36123995 |
| 85 | Arterial thrombosis (HP:0004420) | 2.35578000 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.33810907 |
| 87 | Axonal loss (HP:0003447) | 2.33223381 |
| 88 | Petechiae (HP:0000967) | 2.32827823 |
| 89 | Purpura (HP:0000979) | 2.32824737 |
| 90 | Leukocytosis (HP:0001974) | 2.32547993 |
| 91 | Nephritis (HP:0000123) | 2.32501447 |
| 92 | Increased serum ferritin (HP:0003281) | 2.32304126 |
| 93 | Gingival bleeding (HP:0000225) | 2.28124764 |
| 94 | Thrombocytosis (HP:0001894) | 2.23305446 |
| 95 | Eosinophilia (HP:0001880) | 2.21178105 |
| 96 | Abnormality of T cells (HP:0002843) | 2.20566406 |
| 97 | Abnormality of complement system (HP:0005339) | 2.19685093 |
| 98 | Prostate neoplasm (HP:0100787) | 2.18038917 |
| 99 | IgA deficiency (HP:0002720) | 2.15087112 |
| 100 | Hemoptysis (HP:0002105) | 2.14603323 |
| 101 | Skin ulcer (HP:0200042) | 2.11721757 |
| 102 | Agnosia (HP:0010524) | 2.11337532 |
| 103 | Glomerulopathy (HP:0100820) | 2.11032861 |
| 104 | Sepsis (HP:0100806) | 2.10810921 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 2.10664720 |
| 106 | Thick nail (HP:0001805) | 2.10550563 |
| 107 | Emphysema (HP:0002097) | 2.10362120 |
| 108 | Abnormality of the peritoneum (HP:0002585) | 2.10007916 |
| 109 | Microcytic anemia (HP:0001935) | 2.09451525 |
| 110 | Hepatosplenomegaly (HP:0001433) | 2.08157154 |
| 111 | Increased IgE level (HP:0003212) | 2.06645825 |
| 112 | Vertigo (HP:0002321) | 2.06319834 |
| 113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.06010617 |
| 114 | Viral hepatitis (HP:0006562) | 2.05613876 |
| 115 | Recurrent sinusitis (HP:0011108) | 2.05231669 |
| 116 | Chronic sinusitis (HP:0011109) | 2.04873375 |
| 117 | Polyneuropathy (HP:0001271) | 2.04634366 |
| 118 | Lymphopenia (HP:0001888) | 2.04595844 |
| 119 | Keratoconjunctivitis sicca (HP:0001097) | 2.01118686 |
| 120 | Abnormality of the endocardium (HP:0004306) | 2.00514274 |
| 121 | Premature loss of primary teeth (HP:0006323) | 2.00285682 |
| 122 | Abnormality of the prostate (HP:0008775) | 1.99543966 |
| 123 | Chest pain (HP:0100749) | 1.99233611 |
| 124 | Slow saccadic eye movements (HP:0000514) | 1.98887836 |
| 125 | Restrictive lung disease (HP:0002091) | 1.97406184 |
| 126 | Epistaxis (HP:0000421) | 1.97008695 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.96470484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.10773663 |
| 2 | MAP4K1 | 3.80229629 |
| 3 | TYK2 | 3.71141520 |
| 4 | MAP3K14 | 3.53569979 |
| 5 | IRAK4 | 3.43782526 |
| 6 | RIPK4 | 3.37350878 |
| 7 | TBK1 | 3.02145175 |
| 8 | ERN1 | 2.78190446 |
| 9 | PRPF4B | 2.66098674 |
| 10 | CSK | 2.42768685 |
| 11 | KIT | 2.40028609 |
| 12 | IRAK3 | 2.39350564 |
| 13 | IKBKE | 2.25618090 |
| 14 | TAOK3 | 2.20507941 |
| 15 | JAK1 | 2.14578192 |
| 16 | IKBKB | 2.12220325 |
| 17 | JAK3 | 2.04302229 |
| 18 | TNK2 | 1.97718655 |
| 19 | CSF1R | 1.88302010 |
| 20 | FGR | 1.85532952 |
| 21 | MAP3K3 | 1.78992426 |
| 22 | BTK | 1.78788995 |
| 23 | ZAP70 | 1.73480276 |
| 24 | SYK | 1.72312906 |
| 25 | MATK | 1.71777299 |
| 26 | MAP3K13 | 1.68296942 |
| 27 | STK10 | 1.63388462 |
| 28 | TAOK1 | 1.62494785 |
| 29 | HCK | 1.50395332 |
| 30 | TGFBR2 | 1.48529657 |
| 31 | EPHB1 | 1.46141394 |
| 32 | TEC | 1.42313366 |
| 33 | PIM2 | 1.38816941 |
| 34 | LYN | 1.37038982 |
| 35 | FES | 1.29849242 |
| 36 | NEK9 | 1.25871190 |
| 37 | MAP3K1 | 1.23722087 |
| 38 | PIM1 | 1.20509862 |
| 39 | SIK2 | 1.20000663 |
| 40 | CHUK | 1.18888809 |
| 41 | TXK | 1.15482766 |
| 42 | LCK | 1.15196252 |
| 43 | MAP3K10 | 1.11187254 |
| 44 | CLK1 | 1.09793581 |
| 45 | GRK6 | 1.05674976 |
| 46 | MAP2K3 | 1.01850335 |
| 47 | JAK2 | 1.01402713 |
| 48 | KSR2 | 1.01377659 |
| 49 | YES1 | 0.97642539 |
| 50 | RPS6KA4 | 0.97593467 |
| 51 | ITK | 0.93831636 |
| 52 | BMX | 0.90964585 |
| 53 | MARK2 | 0.90522830 |
| 54 | FGFR4 | 0.90428842 |
| 55 | CDK12 | 0.86528228 |
| 56 | MARK3 | 0.83466550 |
| 57 | PBK | 0.83154923 |
| 58 | MAP3K11 | 0.80849978 |
| 59 | BMPR2 | 0.80745586 |
| 60 | FGFR3 | 0.78079113 |
| 61 | STK4 | 0.77922418 |
| 62 | TRPM7 | 0.74366025 |
| 63 | MAP3K6 | 0.72861047 |
| 64 | PRKD2 | 0.72357739 |
| 65 | CDK19 | 0.72254856 |
| 66 | MAPK7 | 0.71478368 |
| 67 | LRRK2 | 0.71010504 |
| 68 | TESK2 | 0.69116079 |
| 69 | ABL1 | 0.66061449 |
| 70 | RPS6KA6 | 0.65847156 |
| 71 | PIK3CG | 0.65280650 |
| 72 | MAPK12 | 0.64803458 |
| 73 | MAP3K5 | 0.60644496 |
| 74 | CDK6 | 0.60634914 |
| 75 | EGFR | 0.60439347 |
| 76 | MAP3K7 | 0.57687995 |
| 77 | RPS6KL1 | 0.57098611 |
| 78 | RPS6KC1 | 0.57098611 |
| 79 | PRKCD | 0.56524968 |
| 80 | MAPK11 | 0.55259020 |
| 81 | SMG1 | 0.55150792 |
| 82 | MAPK15 | 0.55036331 |
| 83 | PTK2B | 0.55020250 |
| 84 | GRK7 | 0.53290690 |
| 85 | MAPKAPK2 | 0.51755066 |
| 86 | PRKCQ | 0.49018818 |
| 87 | SIK3 | 0.48247478 |
| 88 | ABL2 | 0.47831995 |
| 89 | SGK3 | 0.47754206 |
| 90 | MAP3K2 | 0.47187773 |
| 91 | CDK9 | 0.46551276 |
| 92 | CAMK1D | 0.46535672 |
| 93 | STK11 | 0.44687540 |
| 94 | DYRK1B | 0.44017108 |
| 95 | EPHA3 | 0.43922613 |
| 96 | MAPK4 | 0.43620984 |
| 97 | CDC42BPA | 0.43426878 |
| 98 | PDK1 | 0.40284408 |
| 99 | IRAK1 | 0.39876548 |
| 100 | CAMKK2 | 0.38712938 |
| 101 | FLT3 | 0.38189596 |
| 102 | TAOK2 | 0.36546664 |
| 103 | NLK | 0.34773412 |
| 104 | CAMKK1 | 0.33753252 |
| 105 | NME2 | 0.33379717 |
| 106 | MAP3K8 | 0.32828232 |
| 107 | PDPK1 | 0.31729107 |
| 108 | EIF2AK2 | 0.31599833 |
| 109 | RAF1 | 0.31326453 |
| 110 | FYN | 0.31112515 |
| 111 | SIK1 | 0.30871627 |
| 112 | MOS | 0.30714230 |
| 113 | MAP2K6 | 0.30638160 |
| 114 | CDK4 | 0.30547884 |
| 115 | DAPK2 | 0.30374159 |
| 116 | MAP2K4 | 0.30367488 |
| 117 | RET | 0.30238932 |
| 118 | SGK2 | 0.30046889 |
| 119 | PTK6 | 0.29960407 |
| 120 | HIPK2 | 0.29817704 |
| 121 | RIPK1 | 0.29630684 |
| 122 | TRIB3 | 0.29616774 |
| 123 | TTN | 0.27922910 |
| 124 | ICK | 0.26372277 |
| 125 | ERBB3 | 0.24586618 |
| 126 | MAPK3 | 0.24326173 |
| 127 | MST4 | 0.24141884 |
| 128 | RPS6KA1 | 0.24061768 |
| 129 | INSR | 0.23638714 |
| 130 | PAK4 | 0.22803909 |
| 131 | IRAK2 | 0.21100756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.46235408 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.39633465 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.82073370 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.63372282 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.62503247 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58502209 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.45724887 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39180803 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.27899886 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.26283611 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.22139556 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.21350787 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.16980572 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08175182 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.00838246 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98859904 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.98507993 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.98339281 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.97530602 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.95977258 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.95232598 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91381156 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.89957527 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.82150297 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79500080 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74993201 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72599715 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63550009 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60351644 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58939728 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.57280605 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56390493 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.55508462 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47070974 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.44633581 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42404448 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.39493977 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35814164 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.35015489 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34148293 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31998247 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.25955945 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.25307204 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14630460 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.09945837 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05314218 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95700784 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94071262 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90497213 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88904524 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86237968 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83593962 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82960024 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82483734 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82228470 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80753339 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79871507 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79628691 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78823219 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76594650 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75093266 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.74177130 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72130278 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69789107 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68834936 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68617222 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63293425 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62981083 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 0.61422437 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58720337 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58681616 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57452774 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56814879 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54911261 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.54563976 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52668938 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52418797 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49654215 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47501372 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45475969 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45205031 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44282038 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44107972 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41248652 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40372714 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40355022 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39558559 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.38465365 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37351845 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36838542 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34773662 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.34118317 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33487816 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33261109 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32825962 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.31820894 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29959627 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28431381 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28272295 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26291622 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25975104 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.22986213 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22212801 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.22163509 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22000690 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21451968 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21050341 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20483001 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19921843 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16737490 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.16201394 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15690553 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.15614552 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14206550 |
| 115 | Adherens junction_Homo sapiens_hsa04520 | 0.13876460 |

